Prosecution Insights
Prosecution Insights
11 pending office actions • 9 art units • 10 examiners • 0 of 11 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 10 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 10 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (9%) |
| §103 only | 5 (45%) |
| §102 only | 1 (9%) |
| §112 only | 4 (36%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PENNINGTON, KATIE LEIGH | 2 | 27.3% | +60.6% |
| GHIMIRE, SHANKAR RAJ | 1 | 76.3% | +19.3% |
| VOORHEES, CATHERINE M | 1 | 83.3% | +14.4% |
| SEVERSON, RYAN J | 1 | 83.0% | +13.4% |
| GOLDBERG, JEANINE ANNE | 1 | 46.0% | +40.4% |
| KAPUSHOC, STEPHEN THOMAS | 1 | 46.6% | +52.8% |
| MARVICH, MARIA | 1 | 54.7% | +27.4% |
| DACE DENITO, ALEXANDRA GERALDINE | 1 | 56.5% | +36.3% |
| EMCH, GREGORY S | 1 | 49.0% | +44.3% |
| PARK, HAEJIN S | 1 | 55.3% | +37.9% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18564380 | MRI-CT-COMPATIBLE REMOTE-CONTROLLED MICROPOSITIONING SYSTEM | SEVERSON, RYAN J | 13d |
| 18692402 | MEDICAL HANDLING SYSTEM | VOORHEES, CATHERINE M | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17615453 | COMPOSITIONS AND PROCESS FOR INTEGRATING CELLS INTO EPITHELIUM | PENNINGTON, KATIE LEIGH | 99d overdue |
| 17631598 | ANALYTICAL METHOD AND IMMUNOLOGICAL TREATMENT FOR BLADDER CANCER | EMCH, GREGORY S | 53d overdue |
| 17800338 | Viral vector particle based on AA V2 for gene therapy | PENNINGTON, KATIE LEIGH | 17d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17610611 | METHOD FOR COATING A MEDICAL DEVICE AND COATED MEDICAL DEVICE | PARK, HAEJIN S | 139d overdue |
| 18007200 | LONG NON-CODING RNA AS THERAPEUTIC TARGET IN CARDIAC DISORDERS AND CARDIAC REGENERATION | GOLDBERG, JEANINE ANNE | 128d overdue |
| 17615453 | COMPOSITIONS AND PROCESS FOR INTEGRATING CELLS INTO EPITHELIUM | PENNINGTON, KATIE LEIGH | 99d overdue |
| 17658957 | LNCRNAS FOR THERAPY AND DIAGNOSIS OF CARDIAC HYPERTROPHY | DACE DENITO, ALEXANDRA GERALDINE | 79d overdue |
| 17631598 | ANALYTICAL METHOD AND IMMUNOLOGICAL TREATMENT FOR BLADDER CANCER | EMCH, GREGORY S | 53d overdue |
| 17811995 | LNCRNAS FOR THERAPY AND DIAGNOSIS OF CARDIAC HYPERTROPHY | KAPUSHOC, STEPHEN THOMAS | 28d overdue |
| 17768778 | NON-CODING RNA PROTECTING AGAINST HEART FAILURE | MARVICH, MARIA | 24d overdue |
| 17800338 | Viral vector particle based on AA V2 for gene therapy | PENNINGTON, KATIE LEIGH | 17d overdue |
| Art Unit | Apps |
|---|---|
| 1634 | 3 |
| 3795 | 1 |
| 3792 | 1 |
| 3771 | 1 |
| 1682 | 1 |
| 1683 | 1 |
| 1636 | 1 |
| 1678 | 1 |
| 1614 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18727815 | SUCTION-FLUSHING-SYSTEM AND MEDICAL INSTRUMENT | GHIMIRE, SHANKAR RAJ | 3795 | §103 | Non-Final OA | 29d | Pending | Jul 10, 2024 |
| 18692402 | MEDICAL HANDLING SYSTEM | VOORHEES, CATHERINE M | 3792 | §103 | Final Rejection | — | Pending | Mar 15, 2024 |
| 18564380 | MRI-CT-COMPATIBLE REMOTE-CONTROLLED MICROPOSITIONING SYSTEM | SEVERSON, RYAN J | 3771 | §103 | Non-Final OA | 13d | Pending | Dec 13, 2023 |
| 18007200 | LONG NON-CODING RNA AS THERAPEUTIC TARGET IN CARDIAC DISORDERS AND CARDIAC REGENERATION | GOLDBERG, JEANINE ANNE | 1682 | §102 | Non-Final OA | 128d overdue | Pending | Jan 27, 2023 |
| 17800338 | Viral vector particle based on AA V2 for gene therapy | PENNINGTON, KATIE LEIGH | 1634 | §112 | Non-Final OA | 17d overdue | Pending | Aug 17, 2022 |
| 17811995 | LNCRNAS FOR THERAPY AND DIAGNOSIS OF CARDIAC HYPERTROPHY | KAPUSHOC, STEPHEN THOMAS | 1683 | §112 | Final Rejection | 28d overdue | Pending | Jul 12, 2022 |
| 17768778 | NON-CODING RNA PROTECTING AGAINST HEART FAILURE | MARVICH, MARIA | 1634 | §112 | Final Rejection | 24d overdue | Pending | Apr 13, 2022 |
| 17658957 | LNCRNAS FOR THERAPY AND DIAGNOSIS OF CARDIAC HYPERTROPHY | DACE DENITO, ALEXANDRA GERALDINE | 1636 | §112 | Non-Final OA | 79d overdue | Pending | Apr 12, 2022 |
| 17631598 | ANALYTICAL METHOD AND IMMUNOLOGICAL TREATMENT FOR BLADDER CANCER | EMCH, GREGORY S | 1678 | §101 | Final Rejection | 53d overdue | Pending | Jan 31, 2022 |
| 17615453 | COMPOSITIONS AND PROCESS FOR INTEGRATING CELLS INTO EPITHELIUM | PENNINGTON, KATIE LEIGH | 1634 | §103 | Final Rejection | 99d overdue | Pending | Nov 30, 2021 |
| 17610611 | METHOD FOR COATING A MEDICAL DEVICE AND COATED MEDICAL DEVICE | PARK, HAEJIN S | 1614 | §103 | Final Rejection | 139d overdue | Pending | Nov 11, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial